Cargando…

Does diabetes risk after SARS-CoV-2 infection depend on the viral variant?

SARS-CoV-2 infection is associated with an elevated risk of new-onset diabetes. With infections forecast to rise in the coming months, this may exacerbate an existing public health crisis by increasing rates of diabetes worldwide. Much remains to be learned about a causal link between SARS-CoV-2 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rangu, Rohita, Wander, Pandora L., Zraika, Sakeneh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420316/ https://www.ncbi.nlm.nih.gov/pubmed/36038088 http://dx.doi.org/10.1016/j.diabres.2022.110054

Ejemplares similares

Distinct viral clades of SARS‐CoV‐2: Implications for modeling of viral spread
por: Brufsky, Adam
Publicado: (2020)

A Mouse Model of Beta-Cell Dysfunction as Seen in Human Type 2 Diabetes
por: Parilla, Jacqueline H., et al.
Publicado: (2018)

The mysterious origins of the Omicron variant of SARS-CoV-2
por: Du, Pei, et al.
Publicado: (2022)

Why is the SARS-CoV-2 Omicron variant milder?
por: Xia, Bingqing, et al.
Publicado: (2022)

Is the Omicron variant of SARS-CoV-2 coming to an end?
por: Zhao, Yingjie, et al.
Publicado: (2022)

Do SARS-CoV-2 Variants Differ in Their Neuropathogenicity?
por: Bauer, Lisa, et al.
Publicado: (2023)

Multicomponent vaccines to fight SARS-CoV-2 variants of concern
por: Cassone, Antonio, et al.
Publicado: (2021)

Role of Omicron variant of SARS-CoV-2 in children in Germany
por: Bittmann, Stefan
Publicado: (2022)

SARS-CoV-2 Evolution: On the Sudden Appearance of the Omicron Variant
por: Berkhout, Ben, et al.
Publicado: (2022)

Does the SARS-CoV-2 spike really have an Achilles heel?
por: Pillai, Shiv
Publicado: (2023)

COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants
por: Cevik, Muge, et al.
Publicado: (2021)

Public health actions to control new SARS-CoV-2 variants
por: Grubaugh, Nathan D., et al.
Publicado: (2021)

The omicron variant of SARS‐CoV‐2: Understanding the known and living with unknowns
por: Ingraham, Nicholas E., et al.
Publicado: (2021)

Alpha variant SARS-CoV-2 infection: How it all starts
por: Domingo, Pere, et al.
Publicado: (2021)

Omicron variant of SARS-CoV-2 – A new kid on the block
por: Husain, Uneza, et al.
Publicado: (2022)

Approach to Assessment of New Swabs and Viral Transport Media for SARS-CoV-2 Testing
por: Locher, Kerstin, et al.
Publicado: (2021)

Does SARS-CoV-2 re-infection depend on virus variant?
por: Gautret, Philippe, et al.
Publicado: (2021)

SARS-CoV-2 Mutations and their Viral Variants
por: Cosar, Begum, et al.
Publicado: (2022)

Time to Treat: Applying Lessons Learned from Other Viral Syndromes to SARS-CoV-2
por: Stevens, Ryan W., et al.
Publicado: (2020)

Low Viral Diversity Limits the Effectiveness of Sequence-Based Transmission Inference for SARS-CoV-2
por: Farjo, Mireille, et al.
Publicado: (2023)

Rapid and accurate identification of SARS-CoV-2 variants containing E484 mutation
por: Zhang, Yuan, et al.
Publicado: (2021)

SARS‐CoV‐2 Omicron variant: Why global communities should take it seriously?
por: Rahmani, Shayan, et al.
Publicado: (2022)

SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition
por: Altmann, Daniel M., et al.
Publicado: (2021)

Evaluation of vaccine effectiveness against SARS‐CoV‐2 variants by serological epitope profiling
por: Li, Cheng, et al.
Publicado: (2023)

2019nCoVR—A comprehensive genomic resource for SARS-CoV-2 variant surveillance
por: Lu, Guoqing, et al.
Publicado: (2021)

The Incidence of Diabetes Among 2,777,768 Veterans With and Without Recent SARS-CoV-2 Infection
por: Wander, Pandora L., et al.
Publicado: (2022)

Lifestyle and severe SARS-CoV-2 infections: Does the individual metabolic burden determines the outcome?
por: Markus, Birgit, et al.
Publicado: (2020)

Does SARS-CoV-2 Trigger Stress-Induced Autoimmunity by Molecular Mimicry? A Hypothesis
por: Cappello, Francesco, et al.
Publicado: (2020)

The role of multiple SARS-CoV-2 viral antigens in a vaccine-induced integrated immune response
por: Zhang, Ying, et al.
Publicado: (2021)

Carbon nanomaterials as promising substrates in the design of sensors for SARS-CoV-2 and new emerging viral infections
por: Abbaszadeh, Sepideh, et al.
Publicado: (2021)

Glimpses into evolutionary trajectories of SARS-CoV-2: emerging variants and potential immune evasion routes
por: Anastassopoulou, Cleo, et al.
Publicado: (2021)

Emerging SARS-CoV-2 Variants and Subvariants: Challenges and Opportunities in the Context of COVID-19 Pandemic
por: Rahman, Smaranika, et al.
Publicado: (2022)

Mandatory COVID-19 vaccination for healthcare personnel in the era of new SARS-CoV-2 variants
por: Maltezou, Helena C., et al.
Publicado: (2022)

Pathogenicity of SARS‐CoV‐2 Omicron
por: Chu, Hin, et al.
Publicado: (2022)

Antigenic imprinting in SARS‐CoV‐2
por: Reincke, S. Momsen, et al.
Publicado: (2022)

A new perspective for mitigation of SARS-CoV-2 infection: priming the innate immune system for viral attack
por: Kolodny, Oren, et al.
Publicado: (2020)

Integration of SARS-CoV-2 RNA in infected human cells by retrotransposons: an unlikely hypothesis and old viral relationships
por: Grandi, Nicole, et al.
Publicado: (2021)

Evolution of SARS-CoV-2: BA.4/BA.5 Variants Continues to Pose New Challenges
por: Quadir, Neha, et al.
Publicado: (2022)

A Commentary on “Omicron SARS-CoV-2 variant: Reasons of emergence and lessons learnt” (Int J Surg 2022;97:106198) Contact-tracing and global vaccine equity: Crucial responses to emergence of the Omicron SARS-CoV-2 variant
por: Rahimi, Farid, et al.
Publicado: (2022)

SARS-CoV-2 infection is associated with higher odds of insulin treatment but not with hemoglobin A1c at 120 days in U.S. Veterans with new-onset diabetes
por: Wander, Pandora L., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bolcdqkgbdfd9ptq3q30disccf